Posters
Clinical comparison of two complementary IOLs with new diffractive design against bifocal IOLs
Poster Details
First Author: T.Raffray FRANCE
Co Author(s): J. Bertholom T. Louesdon A. Massot
Abstract Details
Purpose:
To compare clinical outcomes with 2 complementary IOLs with new diffractive design to those with bifocal IOLs
Setting:
Centre Vision Bretagne, Vannes, France
Methods:
In this non-randomised controlled trial, patients were bilaterally implanted either with bifocal +3D ARTIS PL M IOLs or with +2.5D/+3D ARTIS PL M IOLs or with ARTIS ACTIVE MID/PLUS IOLs. The postoperative visits were scheduled at 1 day, 1-2 month, and at 4 to 6 months. The distance, intermediate and near visual acuities (4 m, 70 cm, 40 cm), defocus curve, contrast sensitivity consisted in the objective measurements. Patient questionnaire assessed patient satisfaction.
Results:
25 patients were included in the study. No significant difference was found between groups in the distance, intermediate and near visual acuity. A significant difference was found at -1D and -1.5D in the binocular distance-corrected defocus curve demonstrating better visual acuity in the group implanted with the MID/PLUS IOL with respect to+3D/+2.5D-or +3D+3D add bifocal IOL. MID/PLUS group displayed a continuous sharp vision with the defocus, while the combination of bifocal IOLs did not avoid the drop of visual acuity in the intermediate range. Contrast sensitivities were comparable. Patient’s satisfaction was high in all groups.
Conclusions:
MID and PLUS displayed a continuous defocus curve while mix and match of bifocal IOLs remains a good option for provided near and intermediate vision for special eyes (important kappa angle, myopia greater than 3D, pupil greater than 3 mm, old patients).
Financial Disclosure:
... has significant investment interest in a company producing, developing or supplying product or procedure presented, ... travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, ... research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented
